Cargando…

Current Pharmacological Treatment of Painful Diabetic Neuropathy: A Narrative Review

Background and Objectives: Distal symmetrical polyneuropathy (DSPN) is one of the most common chronic complications of diabetes mellitus. Although it is usually characterized by progressive sensory loss, some patients may develop chronic pain. Assessment of DSPN is not difficult, but the biggest cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ardeleanu, Valeriu, Toma, Alexandra, Pafili, Kalliopi, Papanas, Nikolaos, Motofei, Ion, Diaconu, Camelia Cristina, Rizzo, Manfredi, Pantea Stoian, Anca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022869/ https://www.ncbi.nlm.nih.gov/pubmed/31936646 http://dx.doi.org/10.3390/medicina56010025

Ejemplares similares

Skin AGEs and diabetic neuropathy
por: Papachristou, Stella, et al.
Publicado: (2021)

Letter to the Editor Regarding: Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Pafili, Kalliopi, et al.
Publicado: (2016)

Metabolic disorders during pregnancy and postpartum cardiometabolic risk
por: Patti, Angelo Maria, et al.
Publicado: (2018)

Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus
por: Pafili, Kalliopi, et al.
Publicado: (2020)

Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes
por: Patti, Angelo Maria, et al.
Publicado: (2022)

Diabetic neuropathy: A narrative review of risk factors, classification, screening and current pathogenic treatment options (Review)
por: Bondar, Andrei, et al.
Publicado: (2021)

Clinical Psychological Figures in Healthcare Professionals: Resilience and Maladjustment as the “Cost of Care”
por: Merlo, Emanuele Maria, et al.
Publicado: (2020)

The Role of Suppression and the Maintenance of Euthymia in Clinical Settings
por: Merlo, Emanuele Maria, et al.
Publicado: (2021)

Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review
por: Popovic, Djordje S., et al.
Publicado: (2021)

Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus
por: Chatzikosma, Georgia, et al.
Publicado: (2016)

An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2022)

Diabetes, Vascular Aging and Stroke: Old Dogs, New Tricks?
por: Penlioglou, Theano, et al.
Publicado: (2021)

Clinical Study of Serum Serotonin as a Screening Marker for Anxiety and Depression in Patients with Type 2 Diabetes
por: Moroianu, Lavinia-Alexandra, et al.
Publicado: (2022)

The Role of Fructose as a Cardiovascular Risk Factor: An Update
por: Busnatu, Stefan-Sebastian, et al.
Publicado: (2022)

Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2023)

COVID-19 and diabetes management: What should be considered?
por: Ceriello, Antonio, et al.
Publicado: (2020)

The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review
por: Gouveri, Evanthia, et al.
Publicado: (2022)

Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies
por: Rizvi, Ali Abbas, et al.
Publicado: (2021)

Skin Advanced Glycation End Products among Subjects with Type 2 Diabetes Mellitus with or without Distal Sensorimotor Polyneuropathy
por: Papachristou, Stella, et al.
Publicado: (2021)

Low-density lipoprotein cholesterol lowering treatment: the current approach
por: Crismaru, Irina, et al.
Publicado: (2020)

The Diagnostic Utility of VibraTip for Distal Symmetrical Polyneuropathy in Type 2 Diabetes Mellitus
por: Papanas, Nikolaos, et al.
Publicado: (2019)

Endocrinology in the Time of COVID-19: A Rapid Evolution of Knowledge and Care
por: Rizvi, Ali A., et al.
Publicado: (2021)

Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options
por: Rizvi, Ali A., et al.
Publicado: (2021)

Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview
por: Katsiki, Niki, et al.
Publicado: (2020)

Editorial: Diet-microbe-host interactions in metabolic syndrome
por: Gradisteanu Pircalabioru, Gratiela, et al.
Publicado: (2023)

Diabetic Neuropathy Collection: Progress in Diagnosis and Screening
por: Papanas, Nikolaos
Publicado: (2020)

Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study
por: Nikolic, Dragana, et al.
Publicado: (2022)

New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry
por: Papachristou, Stella, et al.
Publicado: (2020)

Influence of GSTM1, GSTT1, and GSTP1 Polymorphisms on Type 2 Diabetes Mellitus and Diabetic Sensorimotor Peripheral Neuropathy Risk
por: Stoian, Adina, et al.
Publicado: (2015)

Reconnoitering the Therapeutic Role of Curcumin in Disease Prevention and Treatment: Lessons Learnt and Future Directions
por: Sivani, Bala Mohan, et al.
Publicado: (2022)

Is There a Relationship between COVID-19 and Hyponatremia?
por: Gheorghe, Gina, et al.
Publicado: (2021)

Corneal confocal microscopy: Recent progress in the evaluation of diabetic neuropathy
por: Papanas, Nikolaos, et al.
Publicado: (2015)

Treatment with Statins in Elderly Patients
por: Horodinschi, Ruxandra-Nicoleta, et al.
Publicado: (2019)

New Sub-Phenotyping of Subjects at High Risk of Type 2 Diabetes: What Are the Potential Clinical Implications?
por: Popovic, Djordje S., et al.
Publicado: (2021)

Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)
por: Janić, Miodrag, et al.
Publicado: (2022)

Diabetic Peripheral Neuropathy and Depression: Dancing with Wolves? - Mini-Review and Commentary on Alghafri et al. “Screening for depressive symptoms amongst patients with diabetic peripheral neuropathy”
por: Vas, Prashanth R.J., et al.
Publicado: (2021)

APOE gene polymorphisms and diabetic peripheral neuropathy
por: Monastiriotis, Christodoulos, et al.
Publicado: (2012)

Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review
por: Cicero, Arrigo F. G., et al.
Publicado: (2023)

Polypharmacy in Type 2 Diabetes Mellitus: Insights from an Internal Medicine Department
por: Dobrică, Elena-Codruța, et al.
Publicado: (2019)

A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies
por: Vekic, Jelena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b3hl7i7s3tt44r5dlstu2qq0p9